| dc.date.accessioned | 2023-11-07T17:38:41Z | |
| dc.date.available | 2023-11-07T17:38:41Z | |
| dc.date.issued | 2021-03-16 | |
| dc.identifier | pat10947198 | |
| dc.identifier.uri | https://hdl.handle.net/11244/339964 | |
| dc.description.abstract | Chemical compounds that inhibit cancer cell growth are provided. The compounds are heteroarotinoids and derivatives thereof with oxygen, nitrogen or sulfur in chroman systems, tetrahydroquinoline systems, and tetrahydrothiochroman systems. | |
| dc.format | application/pdf | |
| dc.format.extent | 42 pages | |
| dc.language | en_US | |
| dc.publisher | U.S. Patent and Trademark Office | |
| dc.title | Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents | |
| dc.type | Text | |
| osu.filename | pat10947198.pdf | |
| osu.accesstype | Open Access | |
| dc.type.genre | Patent | |
| dc.contributor.inventor | Gnanasekaran, Krishna K. | |
| dc.contributor.inventor | Berlin, Kenneth D. | |
| dc.contributor.inventor | Watts, Field M., Jr. | |
| dc.contributor.inventor | Zhou, Dongjiao | |
| dc.contributor.inventor | Bunce, Richard A. | |
| dc.identifier.patentID | 10947198 | |
| dc.date.filed | 2019-08-23 | |
| dc.contributor.assignee | The Board of Regents for Oklahoma State University | |
| dc.subject.cpcclasses | C07D 215/06 (2013.01) | |
| dc.subject.cpcclasses | A61P 35/00 (2018.01) | |
| dc.subject.cpcclasses | C07D 311/70 (2013.01) | |
| dc.subject.cpcclasses | C07D 335/06 (2013.01) | |
| dc.subject.cpcclasses | A61K 31/352 (2013.01) | |
| dc.subject.cpcclasses | A61K 31/382 (2013.01) | |
| dc.subject.cpcclasses | A61K 31/47 (2013.01) | |
